Figure 3From: The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceGrowth of Tumor #2 is also significantly inhibited during treatment with Apo2L/TRAIL. A. Control; B. Apo2L/TRAIL treated. (4 mice/group; day 35, p = 0.016). Following cessation of treatment (arrows), growth of treated tumors progressed at a rate similar to that of the untreated tumors.Back to article page